Centogene Long Term Debt 2019-2023 | CNTG
Centogene Annual Long Term Debt (Millions of US $) |
|
---|---|
2023 | $43 |
2022 | $42 |
2021 | $ |
2020 | $0 |
2019 | $2 |
2018 | $15 |
Centogene Quarterly Long Term Debt (Millions of US $) |
|
---|---|
2022-06-30 | $25 |
2022-03-31 | $25 |
2021-12-31 | |
2021-09-30 | $0 |
2021-06-30 | $0 |
2021-03-31 | $0 |
2020-12-31 | $0 |
2020-09-30 | $1 |
2020-06-30 | $1 |
2020-03-31 | $1 |
2019-09-30 | $2 |
2019-06-30 | $14 |
2018-12-31 | $15 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.000B | $0.053B |
Centogene is a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. The Company?s goal is to bring rationality to treatment decisions and to accelerate the development of new orphan drugs by using their knowledge of the global rare disease market, including epidemiological and clinical data and innovative biomarkers. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
GE HealthCare Technologies (GEHC) | United States | $35.257B | 19.36 |
Tempus AI (TEM) | United States | $5.669B | 0.00 |
Hims & Hers Health (HIMS) | United States | $4.401B | 0.00 |
Inspire Medical Systems (INSP) | United States | $3.980B | 0.00 |
Axonics (AXNX) | United States | $3.445B | 0.00 |
Olink Holding AB (publ) (OLK) | Sweden | $3.202B | 0.00 |
IRhythm Technologies (IRTC) | United States | $3.010B | 0.00 |
Azenta (AZTA) | United States | $2.800B | 157.42 |
Enovis (ENOV) | United States | $2.438B | 18.07 |
10x Genomics (TXG) | United States | $2.234B | 0.00 |
Privia Health (PRVA) | United States | $2.022B | 113.00 |
Schrodinger (SDGR) | United States | $1.461B | 0.00 |
Omnicell (OMCL) | United States | $1.229B | 42.48 |
Phreesia (PHR) | United States | $1.177B | 0.00 |
Standard BioTools (LAB) | United States | $0.682B | 0.00 |
Definitive Healthcare (DH) | United States | $0.631B | 0.00 |
Clover Health Investments (CLOV) | United States | $0.621B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.596B | 0.00 |
Health Catalyst (HCAT) | United States | $0.365B | 0.00 |
Talkspace (TALK) | United States | $0.365B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.305B | 0.00 |
Pulmonx (LUNG) | United States | $0.245B | 0.00 |
Butterfly Network (BFLY) | United States | $0.209B | 0.00 |
Outset Medical (OM) | United States | $0.199B | 0.00 |
TruBridge (TBRG) | United States | $0.168B | 9.02 |
P3 Health Partners (PIII) | United States | $0.157B | 0.00 |
American Well (AMWL) | United States | $0.089B | 0.00 |
111 (YI) | China | $0.088B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.080B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.075B | 0.00 |
HeartBeam (BEAT) | United States | $0.071B | 0.00 |
Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
MSP Recovery (LIFW) | United States | $0.057B | 0.00 |
Augmedix (AUGX) | United States | $0.049B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.048B | 0.00 |
Zepp Health (ZEPP) | China | $0.039B | 0.00 |
CareCloud (CCLD) | United States | $0.032B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.031B | 0.00 |
Movano (MOVE) | United States | $0.031B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.026B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
Syra Health (SYRA) | United States | $0.008B | 0.00 |
Biotricity (BTCY) | United States | $0.007B | 0.00 |
Transgenomic (PRPO) | United States | $0.007B | 0.00 |
Predictive Oncology (POAI) | United States | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.003B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.003B | 0.00 |
Zhongchao (ZCMD) | China | $0.003B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |